‘We have goals but [it is difficult]’. Barriers to antiretroviral therapy adherence among women using alcohol and other drugs living with HIV in South Africa
Open accessAbstract
Background: Women living with HIV who misuse alcohol and live in economically disadvantaged settings in South Africa experience a multitude of contextual barriers as they navigate the HIV care continuum. The Women's Health CoOp (WHC), a brief, woman‐focused, behavioural, evidence‐based intervention, has been shown to be effective in reducing heavy drinking and improving HIV‐related outcomes among this key population. However, these women face other broader socioecological barriers to antiretroviral therapy (ART) adherence. Methods: The WHC was implemented in a modified, stepped‐wedge implementation science trial in public health clinics and substance use treatment programmes in Cape Town, South Africa. A qualitative substudy was conducted to explore barriers to HIV treatment adherence among women enrolled in this trial. Eight focus group discussions were conducted with 69 participants 6 months after completion of the WHC workshops. Focus groups were audio‐recorded (with consent), transcribed verbatim and analysed using a thematic approach. Results: The mean age of the participants was 33 years and the mean self‐reported number of drinks per day was 13. The main contextual factors influencing participants’ ART adherence were intrapersonal‐level factors (substance use, financial constraints, food insecurity; community‐level factors (anticipated and enacted stigma, community violence) and institutional‐level factors (patient–provider relationships, health facility barriers, environmental stigma). Conclusion: Comprehensive interventions addressing the contextual barriers and unique challenges faced by women who misuse alcohol in low‐resource settings that intersect with HIV treatment nonadherence should be implemented in tandem with successful biobehavioural HIV interventions for long‐term effectiveness and sustainability. Patient or Public Contribution: Our South African community collaborative board has been involved throughout this study; participants and clinic staff voices have been essential in our interpretation of these findings.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ndirangu et al. (2022) had a duration of six months per cycle.
“Six months”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [63]
Ndirangu et al. (2022) included eight clusters (public health clinics and substance use treatment programs).
“8”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [63]
Ndirangu et al. (2022) used the design to assess barriers to ART adherence from a socio-ecological framework and to facilitate phased implementation and rigorous evaluation of the WHC intervention.
“To assess the barriers to ART adherence from a socio-ecological framework and to facilitate the phased implementation and rigorous evaluation of the WHC intervention”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [63]
Ndirangu et al. (2022) used four steps (cycles) in the stepped wedge design.
“4”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [63]
Ndirangu et al. (2022) randomly selected eligible participants from each of the eight study clinics within each cycle for follow-up focus group discussions, implementing the intervention in a modified stepped-wedge design over four cycles.
“Eligible participants from each of the eight study clinics were randomly selected within each cycle for the follow-up focus group discussions. The intervention was implemented in a modified stepped-wedge design over four cycles, each lasting six months”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [63]
Behavioural and psychosocial interventions benefited from SWD's staged rollout, which is often advantageous for interventions that require time to demonstrate effects.
“Behavioural and psychosocial interventions—such as Women's Health CoOp (63) and Cognitive Stimulation Therapy (102)—also benefited from SWD's staged rollout, which is often advantageous for interventions that require time to demonstrate effects (120, 121).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Stangl, A. L., Earnshaw, V. A., Logie, C. H., van Brakel, W., C. Simbayi, L., Barré, I., & Dovidio, J. F. (2019) · BMC Medicine · doi:10.1186/s12916-019-1271-3 · Cited by 1,603 · see citing works
Govindasamy, D., Ford, N., & Kranzer, K. (2012) · AIDS · doi:10.1097/qad.0b013e3283578b9b · Cited by 435 · see citing works
Treves-Kagan, S., Steward, W. T., Ntswane, L., Haller, R., Gilvydis, J. M., Gulati, H., Barnhart, S., & Lippman, S. A. (2015) · BMC Public Health · doi:10.1186/s12889-016-2753-2 · Cited by 153 · see citing works
Substance Abuse Treatment in Persons with HIV/AIDS: Challenges in Managing Triple Diagnosis
Durvasula, R., & Miller, T. R. (2014) · Behavioral Medicine · doi:10.1080/08964289.2013.866540 · Cited by 151 · see citing works
The MASH Research Team, Scott-Sheldon, L. A. J., Carey, K. B., Johnson, B. T., & Carey, M. P. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1886-3 · Cited by 133 · see citing works
Cichowitz, C., Maraba, N., Hamilton, R., Charalambous, S., & Hoffmann, C. J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189820 · Cited by 38 · see citing works
Wechsberg, W. M., Bonner, C. P., Zule, W. A., van der Horst, C., Ndirangu, J., Browne, F. A., Kline, T. L., Howard, B. N., & Rodman, N. F. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.10.036 · Cited by 32 · see citing works
Self-citationWechsberg, W. M., Browne, F. A., Ndirangu, J., Bonner, C. P., Kline, T. L., Gichane, M., & Zule, W. A. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03251-7 · Cited by 16 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 48
- [3]Simbayi L, Zuma K & Zungu N, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017: towards achieving the UNAIDS 90-90-90 targets. HSRC Press; 2019.
- [4]Kader R, Govender R, Seedat S, Koch JR, Parry C. Understanding the impact of hazardous and harmful use of alcohol and/or other drugs on ARV adherence and disease progression. PLoS One. 2015; 10(5): e0125088. 10.1371/journal.pone.0125088 25933422 PMC4416796 · DOI
- [5]Kalichman S, Mathews C, Banas E, Kalichman M. Alcohol‐related intentional nonadherence to antiretroviral therapy among people living with HIV, Cape Town, South Africa. AIDS Care. 2019; 31(8): 951‐ 957. 10.1080/09540121.2019.1587357 30884956 PMC6541519 · DOI
- [6]Luseno WK, Wechsberg WM, Kline TL, Ellerson RM. Health services utilization among South African women living with HIV and reporting sexual and substance‐use risk behaviors. AIDS Patient Care STDS. 2010; 24(4): 257‐ 264. 10.1089/apc.2009.0213 20377433 PMC2864051 · DOI
- [7]Rehm J, Probst C, Shield KD, Shuper PA. Does alcohol use have a causal effect on HIV incidence and disease progression? A review of the literature and a modeling strategy for quantifying the effect. Popul Health Metr. 2017; 15(1): 4. 10.1186/s12963-017-0121-9 28183309 PMC5301358 · DOI
- [8]Wechsberg WM, Luseno W, Riehman K, Karg R, Browne F, Parry C. Substance use and sexual risk within the context of gender inequality in South Africa. Subst Use Misuse. 2008; 43(8‐9): 1186‐ 1201. 10.1080/10826080801918247 18649238 PMC3129982 · DOI
- [9]Wechsberg WM, Jewkes R, Novak SP, et al. A brief intervention for drug use, sexual risk behaviours and violence prevention with vulnerable women in South Africa: a randomised trial of the Women's Health CoOp. BMJ Open. 2013; 3(5): e002622. PMC3657672 23793683
- [10]Wechsberg WM, Ndirangu JW, Speizer IS, et al. An implementation science protocol of the Women's Health CoOp in healthcare settings in Cape Town, South Africa: a stepped‐wedge design. BMC Womens Health. 2017; 17(1): 85. 10.1186/s12905-017-0433-8 28923034 PMC5604513 · DOI
- [13]Carrasco MA, Esser MB, Sparks A, Kaufman MR. HIV‐alcohol risk reduction interventions in Sub‐Saharan Africa: a systematic review of the literature and recommendations for a way forward. AIDS Behav. 2016; 20(3): 484‐ 503. 10.1007/s10461-015-1233-5 26511865 · DOI
- [15]Wechsberg WM, Zule WA, Luseno WK, et al. Effectiveness of an adapted evidence‐based woman‐focused intervention for sex workers and non‐sex workers: the Women's Health CoOp in South Africa. J Drug Issues. 2011; 41(2): 233‐ 252. 10.1177/002204261104100205 · DOI
- [16]Becker N, Cordeiro LS, Poudel KC, Sibiya TE, Sayer AG, Sibeko LN. Individual, household, and community level barriers to ART adherence among women in rural Eswatini. PLoS One. 2020; 15(4): e0231952. 10.1371/journal.pone.0231952 32343742 PMC7188206 · DOI
- [17]Kagee A, Remien RH, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health. 2011; 6(1): 83‐ 97. 10.1080/17441691003796387 20509066 PMC3056922 · DOI
- [18]Loeliger KB, Niccolai LM, Mtungwa LN, Moll A, Shenoi SV. Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators. AIDS Care. 2016; 28(8): 982‐ 993. 10.1080/09540121.2016.1164292 27043077 PMC4917424 · DOI
- [19]Adimora AA, Auerbach JD. Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr. 2010; 55(suppl 2, 02): S132‐ S135. 10.1097/QAI.0b013e3181fbcb38 21406983 PMC4167624 · DOI
- [20]Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural approaches to HIV prevention. Lancet. 2008; 372(9640): 764‐ 775. 10.1016/s0140-6736(08)60887-9 18687460 · DOI
- [21]Logie CH, Wang Y, Lacombe‐Duncan A, et al. HIV‐related stigma, racial discrimination, and gender discrimination: pathways to physical and mental health‐related quality of life among a national cohort of women living with HIV. Prev Med. 2018; 107: 36‐ 44. 10.1016/j.ypmed.2017.12.018 29277410 · DOI
- [24]Dewey ME. Coefficients of agreement. Br J Psychiatry. 1983; 143(5): 487‐ 489. 6640218
- [25]Davis A, Pala AN, Nguyen N, et al. Sociodemographic and psychosocial predictors of longitudinal antiretroviral therapy (ART) adherence among first‐time ART initiators in Cape Town, South Africa. AIDS Care. 2021; 33(11): 1394‐ 1403. 10.1080/09540121.2020.1798336 32698680 PMC7855439 · DOI
- [27]Fatch R, Emenyonu NI, Muyindike W, Kekibiina A, Woolf‐King S, Hahn JA. Alcohol interactive toxicity beliefs and ART non‐adherence among HIV‐infected current drinkers in Mbarara, Uganda. AIDS Behav. 2017; 21(7): 1812‐ 1824. 10.1007/s10461-016-1429-3 27198557 PMC5116271 · DOI
- [28]Kalichman SC, Amaral CM, White D, et al. Alcohol and adherence to antiretroviral medications: interactive toxicity beliefs among people living with HIV. J Assoc Nurses AIDS Care. 2012; 23(6): 511‐ 520. 10.1016/j.jana.2011.11.005 22421097 PMC4271641 · DOI
- [29]Sundararajan R, Wyatt MA, Woolf‐King S, et al. Qualitative study of changes in alcohol use among HIV‐infected adults entering care and treatment for HIV/AIDS in rural southwest Uganda. AIDS Behav. 2015; 19(4): 732‐ 741. 10.1007/s10461-014-0918-5 25323678 PMC4392168 · DOI
- [32]Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non‐adherence to antiretroviral therapy. AIDS Care. 2017; 29(4): 418‐ 422. 10.1080/09540121.2016.1220478 27535297 PMC5593131 · DOI
- [33]Cornelius T, Jones M, Merly C, Welles B, Kalichman MO, Kalichman SC. Impact of food, housing, and transportation insecurity on ART adherence: a hierarchical resources approach. AIDS Care. 2017; 29(4): 449‐ 457. 10.1080/09540121.2016.1258451 27846730 PMC5291788 · DOI
- [34]Walcott M, Kempf M‐C, Merlin JS, Turan JM. Structural community factors and sub‐optimal engagement in HIV care among low‐income women in the Deep South of the USA. Cult Health Sex. 2016; 18(6): 682‐ 694. 10.1080/13691058.2015.1110255 26670722 PMC6047529 · DOI
- [35]Bepouka B, Situakibanza H, Kiazayawoko F, Aliocha N. P3.23 Determinants of non‐adherence to antiretroviral therapy in adults in the city of Kinshasa. Sex Transm Infect. 2017; 93(suppl 2): A101‐ A102. 10.1136/sextrans-2017-053264.260 · DOI
- [36]Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono‐Kihara M, Kihara M. “If I have nothing to eat, I get angry and push the pills bottle away from me”: a qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care. 2013; 25(10): 1271‐ 1277. 10.1080/09540121.2013.764391 23383757 · DOI
- [37]Pellowski JA, Huedo‐Medina TB, Kalichman SC. Food insecurity, substance use, and sexual transmission risk behavior among people living with HIV: a daily level analysis. Arch Sex Behav. 2018; 47(7): 1899‐ 1907. 10.1007/s10508-017-0942-4 28429158 PMC5650554 · DOI
- [38]Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav. 2014; 18(suppl 5, 05): S505‐ S515. 10.1007/s10461-013-0547-4 23842717 PMC3888651 · DOI
- [39]Igumbor JO, Scheepers E, Ebrahim R, Jason A, Grimwood A. An evaluation of the impact of a community‐based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa. AIDS Care. 2011; 23(2): 231‐ 236. 10.1080/09540121.2010.498909 21259136 · DOI
- [40]Kalichman SC, Washington C, Grebler T, et al. Medication adherence and health outcomes of people living with HIV who are food insecure and prescribed antiretrovirals that should be taken with food. Infect Dis Ther. 2015; 4(1): 79‐ 91. 10.1007/s40121-015-0057-y PMC4363219 25613643 · DOI
- [41]Singer AW, Weiser SD, McCoy SI. Does food insecurity undermine adherence to antiretroviral therapy? A systematic review. AIDS Behav. 2015; 19(8): 1510‐ 1526. 10.1007/s10461-014-0873-1 25096896 · DOI
- [42]Siedner MJ, Santorino D, Lankowski AJ, et al. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study. BMC Med. 2015; 13:160. 10.1186/s12916-015-0397-1 PMC4494725 26149722 · DOI
- [43]Bemelmans M, van den Akker T, Ford N, et al. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health. 2010; 15(12): 1413‐ 1420. 10.1111/j.1365-3156.2010.02649.x 20958897 · DOI
- [44]Cantrell RA, Sinkala M, Megazinni K, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food‐insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008; 49(2): 190‐ 195. 18769349 PMC3847664
- [45]McCoy SI, Njau PF, Fahey C, et al. Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV‐infected adults in Tanzania. AIDS. 2017; 31(6): 815‐ 825. 10.1097/QAD.0000000000001406 28107221 PMC5342932 · DOI
- [46]Tirivayi N, Koethe JR, Groot W. Clinic‐based food assistance is associated with increased medication adherence among HIV‐infected adults on long‐term antiretroviral therapy in Zambia. J AIDS Clin Res. 2012; 3(7):171. 10.4172/2155-6113.1000171 PMC3515057 23227443 · DOI
- [47]Govender V, Fried J, Birch S, Chimbindi N, Cleary S. Disability grant: a precarious lifeline for HIV/AIDS patients in South Africa. BMC Health Serv Res. 2015; 15(1): 227. 10.1186/s12913-015-0870-8 26050715 PMC4459666 · DOI
- [48]Grelotti DJ, Closson EF, Smit JA, et al. Whoonga: potential recreational use of HIV antiretroviral medication in South Africa. AIDS Behav. 2014; 18(3): 511‐ 518. 10.1007/s10461-013-0575-0 23955659 PMC3926908 · DOI
- [49]Kuo C, Giovenco D, DeAtley T, et al. Recreational use of HIV antiretroviral medication and implications for HIV pre‐exposure prophylaxis and treatment. AIDS Behav. 2020; 24(9): 2650‐ 2655. 10.1007/s10461-020-02821-5 32140876 PMC7725396 · DOI
- [50]Rough K, Dietrich J, Essien T, et al. Whoonga and the abuse and diversion of antiretrovirals in Soweto, South Africa. AIDS Behav. 2014; 18(7): 1378‐ 1380. 10.1007/s10461-013-0683-x 24370963 PMC4047174 · DOI
- [51]Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self‐reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009; 24(10): 1101‐ 1108. 10.1007/s11606-009-1068-8 19653047 PMC2762503 · DOI
- [53]Nzaumvila DK, Mabuza LH. Why do women not return for CD4 count results at Embhuleni Hospital, Mpumalanga, South Africa? Curationis. 2015; 38(1), 1266. 10.4102/curationis.v38i1.1266 PMC6091793 26244457 · DOI
- [55]Nyblade L, Addo NA, Atuahene K, et al. Results from a difference‐in‐differences evaluation of health facility HIV and key population stigma‐reduction interventions in Ghana. J Int AIDS Soc. 2020; 23(4): e25483. 10.1002/jia2.25483 32329153 PMC7180216 · DOI
- [56]Nyblade L, Stockton MA, Giger K, et al. Stigma in health facilities: why it matters and how we can change it. BMC Med. 2019; 17(1): 25. 10.1186/s12916-019-1256-2 30764806 PMC6376713 · DOI · Paper page
- [57]Daniel Kelly J, Reid MJ, Lahiff M, Tsai AC, Weiser SD. Community‐level HIV stigma as a driver for HIV transmission risk behaviors and sexually transmitted diseases in Sierra Leone: a population‐based study. J Acquir Immune Defic Syndr. 2017; 75(4): 399‐ 407. 28406807 PMC5524569
- [58]Mwamba C, Sharma A, Mukamba N, et al. ‘They care rudely!’: resourcing and relational health system factors that influence retention in care for people living with HIV in Zambia. BMJ Global Health. 2018;3:e001007. PMC6231098 30483408
- [59]Agarwal R, Rewari BB, Allam RR, Chava N, Rathore AS. Quality and effectiveness of counselling at antiretroviral therapy centres in India: capturing counsellor and beneficiary perspectives. Int Health. 2019; 11(6): 480‐ 486. 10.1093/inthealth/ihy100 30726940 · DOI
- [60]Gichane MW, Wechsberg WM, Ndirangu J, et al. Implementation science outcomes of a gender‐focused HIV and alcohol risk‐reduction intervention in usual‐care settings in South Africa. Drug Alcohol Depend. 2020; 215: 108206. 10.1016/j.drugalcdep.2020.108206 32771909 PMC7502463 · DOI · Paper page
Cited by
Sorted by citations
Musa, Z. A., Akinsolu, F. T., Salako, A. O., Abodunrin, O. R., Ola, O. M., & Ezechi, O. C. (2026) · Frontiers in Epidemiology · doi:10.3389/fepid.2026.1529289
- Authors
- Ndirangu, J. W., Gichane, M. W., Browne, F. A., Bonner, C. P., Zule, W. A., Cox, E. N., Smith, K. M., Carney, T., & Wechsberg, W. M.
- Affiliations
- RTI International (US)
- University of North Carolina at Chapel Hill (US)
- South African Medical Research Council (ZA)
- Corresponding author
- Ndirangu, Jacqueline W.
- ORCID
- Venue
- Health Expectations
- Publisher
- Wiley
- Published
- 2022-01-21
- Volume
- 25
- Issue
- 2
- Pages
- 754-763
- ISSN
- 1369-6513 (ISSN-L)
- 1369-7625
- PMC
- PMC8957738
- OpenAlex
- W4206735946
- Cited by
- 10
- References
- 8
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Health Expectations (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA022882)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- antiretroviral therapy adherence, HIV, women, alcohol abuse, substance use, contextual barriers, stigma, community violence, financial constraints, food insecurity, patient-provider relationship, resource-limited settings, South Africa
- MeSH terms
- Adult, Female, Goals, Humans, Patient Compliance, South Africa, HIV Infections, Anti-Retroviral Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review